| Brent Marc Schillinger, MD | |
|
3100 S Federal Hwy Ste 8, Delray Beach, FL 33483-3320 | |
| (561) 278-1362 | |
| (561) 278-4383 |
| Full Name | Brent Marc Schillinger |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 45 Years |
| Location | 3100 S Federal Hwy Ste 8, Delray Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457332488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | ME0041920 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Total Vein And Skin Llc | 9830476712 | 17 |
News Archive
Due to a change in federal regulation, from 2013-2017, the Centers for Medicare and Medicaid Services redacted any health care encounter that included a diagnosis or procedure code related to substance abuse from the Medicare and Medicaid identifiable files.
Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) issued a positive response to the Qualification Plan (QP) for glutamate dehydrogenase (GLDH) as a safety biomarker for drug-induced liver injury (DILI), developed by C-Path's Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC).
Saccharin, the artificial sweetener that is the main ingredient in Sweet 'N Low, Sweet Twin and Necta, could do far more than just keep our waistlines trim. According to new research, this popular sugar substitute could potentially lead to the development of drugs capable of combating aggressive, difficult-to-treat cancers with fewer side effects.
Doctors Research Group, Inc. announced today that it has received 510(k) approval from the U.S. Food and Drug Administration (FDA) to market KRYPTONITE(TM) Bone Cement for cranioplasty applications.
Some skin wounds, such as diabetic ulcers, are chronic and may never heal; others, such as burn wounds, are often large and difficult to treat, resulting in pain, infection and scarring. Researchers at the University of California, Los Angeles, funded by the National Institutes of Health, have developed a synthetic biomaterial that fills wounds and aids in regeneration of skin cells, which ultimately improves wound healing.
› Verified 8 days ago
| Entity Name | Total Vein And Skin Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437517802 PECOS PAC ID: 9830476712 Enrollment ID: O20170502000919 |
News Archive
Due to a change in federal regulation, from 2013-2017, the Centers for Medicare and Medicaid Services redacted any health care encounter that included a diagnosis or procedure code related to substance abuse from the Medicare and Medicaid identifiable files.
Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) issued a positive response to the Qualification Plan (QP) for glutamate dehydrogenase (GLDH) as a safety biomarker for drug-induced liver injury (DILI), developed by C-Path's Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC).
Saccharin, the artificial sweetener that is the main ingredient in Sweet 'N Low, Sweet Twin and Necta, could do far more than just keep our waistlines trim. According to new research, this popular sugar substitute could potentially lead to the development of drugs capable of combating aggressive, difficult-to-treat cancers with fewer side effects.
Doctors Research Group, Inc. announced today that it has received 510(k) approval from the U.S. Food and Drug Administration (FDA) to market KRYPTONITE(TM) Bone Cement for cranioplasty applications.
Some skin wounds, such as diabetic ulcers, are chronic and may never heal; others, such as burn wounds, are often large and difficult to treat, resulting in pain, infection and scarring. Researchers at the University of California, Los Angeles, funded by the National Institutes of Health, have developed a synthetic biomaterial that fills wounds and aids in regeneration of skin cells, which ultimately improves wound healing.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brent Marc Schillinger, MD 3100 S Federal Hwy Ste 8, Delray Beach, FL 33483-3320 Ph: (561) 278-1362 | Brent Marc Schillinger, MD 3100 S Federal Hwy Ste 8, Delray Beach, FL 33483-3320 Ph: (561) 278-1362 |
News Archive
Due to a change in federal regulation, from 2013-2017, the Centers for Medicare and Medicaid Services redacted any health care encounter that included a diagnosis or procedure code related to substance abuse from the Medicare and Medicaid identifiable files.
Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) issued a positive response to the Qualification Plan (QP) for glutamate dehydrogenase (GLDH) as a safety biomarker for drug-induced liver injury (DILI), developed by C-Path's Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC).
Saccharin, the artificial sweetener that is the main ingredient in Sweet 'N Low, Sweet Twin and Necta, could do far more than just keep our waistlines trim. According to new research, this popular sugar substitute could potentially lead to the development of drugs capable of combating aggressive, difficult-to-treat cancers with fewer side effects.
Doctors Research Group, Inc. announced today that it has received 510(k) approval from the U.S. Food and Drug Administration (FDA) to market KRYPTONITE(TM) Bone Cement for cranioplasty applications.
Some skin wounds, such as diabetic ulcers, are chronic and may never heal; others, such as burn wounds, are often large and difficult to treat, resulting in pain, infection and scarring. Researchers at the University of California, Los Angeles, funded by the National Institutes of Health, have developed a synthetic biomaterial that fills wounds and aids in regeneration of skin cells, which ultimately improves wound healing.
› Verified 8 days ago
Dr. Thomas C. Balshi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4665 W Atlantic Ave, Delray Beach, FL 33445 Phone: 561-272-6000 | |
Dr. Deborah Melanie Saff, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 230 George Bush Blvd, Delray Beach, FL 33444 Phone: 561-276-3111 Fax: 561-276-3319 | |
Larissa Zaulyanov Scanlan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13550 Jog Road, S. D201, Delray Beach, FL 33446 Phone: 561-637-2516 Fax: 561-637-4657 | |
Dr. Meredith Hancock, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6140 W. Atlantic Ave, Delray Beach, FL 33484 Phone: 561-498-4407 Fax: 561-498-4480 | |
Dr. Adam S Plotkin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5210 Linton Blvd, Suite 307, Delray Beach, FL 33484 Phone: 561-499-0660 Fax: 561-499-4094 | |
Dr. Howard Adam Bueller, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5258 Linton Blvd, Suite 306, Delray Beach, FL 33484 Phone: 561-498-2911 Fax: 561-496-0282 | |
Dr. Jacob Kalmanson, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5210 Linton Blvd, Suite 307, Delray Beach, FL 33484 Phone: 561-499-0660 Fax: 561-499-4094 |